Veterinary Medicines

Vanguard Lepto solution injectable pour chiens

Authorised
  • Leptospira interrogans, serovar Canicola, Live
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Live
Download as PDF

Product identification

Medicine name:
Vanguard Lepto solution injectable pour chiens
Vanguard Lepto Injektionslösung
Active substance:
  • Leptospira interrogans, serovar Canicola, Live
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Canicola, Live
    40.00
    unit(s)
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Live
    40.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Available in:
  • Luxembourg
Package description:
  • Vanguard Lepto 1 dose Vial Solution for injection
  • Vanguard Lepto 10 1 dose Vial Solution for injection
  • Vanguard Lepto 25 1 dose Vial Solution for injection
  • Vanguard Lepto 100 1 dose Vial Solution for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium SA
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 087/87/09/0249
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 16/03/2023
Download